BVXV logo

BiondVax Pharmaceuticals (BVXV) Enterprise Value

Enterprise Value

N/A

Mon, 01 Jan 0001 00:00:00 GMT


Summary


Performance

BVXV Enterprise Value Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

OtherBVXVvaluationmetrics:

Enterprise Value Formula

Enterprise Value = Market Cap + Total Debt − Cash & Cash Equivalents

BVXV Enterprise Value Trends

PeriodPeriodEnterprise valueEnterprise valueMarket capMarket capPricePrice
6 m6 months---
1 y1 year---
5 y5 years---

BVXV Enterprise Value Highs & Lows

PeriodPeriodHighHighCurrent vs highvs highLowLowCurrent vs lowvs low
1 m1-month
3 m3-month
6 m6-month
1 y1-year
3 y3-year$46 M$13 M
5 y5-year$615 M$13 M
alltimeall time$615 M-$461 K

BiondVax Pharmaceuticals Enterprise Value History

DateValue
2022
$14.79 M(-73.1%)
2021
$55.03 M(+9.3%)
2020
$50.36 M(-54.4%)
2019
$110.43 M(+206.1%)
DateValue
2018
$36.08 M(+149.0%)
2017
$14.49 M(+100.4%)
2016
$7.23 M(+50.7%)
2015
$4.80 M

FAQ

  • What is the all time high enterprise value for BiondVax Pharmaceuticals?

What is the all time high enterprise value for BiondVax Pharmaceuticals?

BiondVax Pharmaceuticals all-time high enterprise value is $614.95 M